GLP-3 RT 10 mg is the premium research-scale quantity of this triple GIP, incretin, and glucagon receptor agonist peptide, designed for advanced laboratories engaged in large-scale experimental programs, multi-institutional collaborations, or screening campaigns requiring abundant reagent supplies. This substantial quantity of research-grade GLP-3 RT enables investigators to undertake projects of significant scope and ambition, including genome-wide expression profiling studies, high-content imaging campaigns, and multiplexed signaling pathway analyses that characterize the full breadth of cellular responses to triple-receptor activation.

The molecular architecture of GLP-3 RT — a modified peptide backbone incorporating strategic amino acid substitutions and a lipid side chain for enhanced stability — makes it an instructive example of modern rational peptide design principles. Medicinal chemistry researchers studying the effects of sequence modification, lipidation, and linker chemistry on receptor selectivity profiles frequently reference the design of GLP-3 RT as a benchmark for multi-target ligand engineering. The 10 mg format also supports the material needs of laboratories that maintain reference standard libraries or supply peptide to satellite research groups within university or corporate research networks.

Stringent production controls, including environmental monitoring, raw material qualification, and in-process testing, ensure batch-to-batch consistency. LabRat Compounds delivers this product with complete analytical records, including HPLC chromatograms and mass spectra. It is provided exclusively for legitimate scientific research and is not intended for human or animal administration.

FDA DISCLAIMER

The information provided on this website has not been evaluated by the U.S. Food and Drug Administration (FDA). None of the statements herein, nor any of the products offered, are intended to diagnose, treat, cure, or prevent any medical condition.

All products are supplied strictly as laboratory research reagents and are not for human consumption. We do not provide products to patients and do not make any claims regarding medical use.

LabRat Compounds operates solely as a chemical supplier. It is not a compounding pharmacy and does not operate as a compounding facility under Section 503A of the Federal Food, Drug, and Cosmetic Act.